Clinical Trial Update: Impact of P53 and SIRT1 in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial updating on the role of P53 and SIRT1 in type 2 diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: DM | Phase 3 | Status: RECRUITING